Patents by Inventor Rory McAtee

Rory McAtee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic compounds as inhibitors of KRAS
    Patent number: 12600717
    Abstract: Disclosed are compounds of Formula I (shown below), methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.
    Type: Grant
    Filed: July 13, 2022
    Date of Patent: April 14, 2026
    Assignee: Incyte Corporation
    Inventors: Zhenwu Li, Zhiyong Yu, Jeremy Roach, Gia Hoang, Bin Hu, Gencheng Li, Rory McAtee, Ken Mukai, Rocco Policarpo, Robert Susick, Xiaozhao Wang, Wenqing Yao
  • TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
    Publication number: 20230114765
    Abstract: Disclosed are compounds of Formula I, methods of using the compounds for inhibiting KRAS activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with KRAS activity such as cancer.
    Type: Application
    Filed: July 13, 2022
    Publication date: April 13, 2023
    Inventors: Zhenwu Li, Zhiyong YU, Jeremy Roach, Gia Hoang, Bin HU, Gencheng Li, Rory McAtee, Ken Mukai, Rocco Policarpo, Robert Susick, Xiaozhao Wang, Wenqing Yao